AB Biolabs Company News

Providing biomedical research tools

All rights reserved, AB Biolabs, Inc

AB Biolabs launches new competitive immunoassay kit Semaglutide (2-11-2016)

  Ballwin, Missouri. AB Biolabs has launched CEK Semaglutide (CEK 0130-04) in February, 2016. The kit is a 96 wells competitive immunoassay and applied for the analysis of Semaglutide in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.  

Semaglutide is a new glucagon-like peptide-1 (GLP-1) analogue, developed by Novo Nordisk. It can help people with type 2 diabetes achieve substantial improvement of blood glucose with a low risk of hypoglycaemia. In addition, Semaglutide induces weight loss by decreasing appetite and food intake. Its administered subcutaneously once weekly is in development for the treatment of type 2 diabetes and is also being developed in an oral tablet version. The data from trials in 2015 indicate Semaglutide is a hopeful candidate for diabetes treatment.

 
Degarelix competitive Immunoassay kit developed by AB Biolabs (5-20-2015)

 Ballwin, Missouri. Degarelix (tradename Firmagon) is a hormonal therapy used in the treatment of prostate cancer. It approved by FDA and EMEA for the treatment of patients with advanced prostate cancer. Degarelix resulted in a faster reduction in PSA levels compared with leuprolide indicating faster control of the prostate cancer. And the results also suggest that degarelix therapy may result in longer control of prostate cancer compared with leuprolide.

CEK Degarelix (CEK0100-09) is a 96 wells competitive immunoassay and applied for the analysis of Degarelix in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.


New Sandwish Immunoassay Kit for Exenatide is added (12-26-2014)

  Ballwin, Missouri. For special research purpose, new SEK 0130-01C is developed currently. The detect monoclonal AB is limited to be linked neither biotin nor HRP in assay. This 96 wells sandwich immunoassay kit has been added to Exenatide assay product line. It also is applied for the analysis of Exenatide in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.


Oxyntomodukin sandwich immunoassay kit has been developed (11-25-2013)

  Ballwin, Missouri. Oxyntomodulin Sandwich immunoassay kit (SEK 0160-01) is available at AB Biolabs. SEK Oxyntomodulin (SEK 0160-01) is 96 wells sandwich immunoassay kit. It is applied for the analysis of Oxyntomodulin in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.

Oxyntomodulin (Glucagon 37) is a naturally occurring 37 amino acid peptide hormone found in the colon. It has been found to suppress appetite. A recent study has found that it can be used as a weight loss treatment. The mechanism of action of oxyntomodulin is not well understood. It is known to bind both the GLP-1 receptor and the glucagon receptor but it is not known whether the effects of the hormone are mediated through these receptors or through an unidentified receptor.


CEK Chrysalin (PT508) kit is now available (06/29/2011)

    Ballwin, Missouri. AB Biolabs has launched a new CEK Chrysalin (PT508) kit (CEK0280-00). This kit is 96 well format, and can be applied for detection of Chrysalin peptide in the concentration range of 0.01 to 1000 ng/ml.


AB Biolabs has developed CEK Liraglutide kit (04/19/2010)

    Ballwin, Missouri. AB Biolabs has launched a new CEK Liraglutide kit. Liraglutide (Brand name Victoza) is a long-acting glucagon-like peptide-1 (GLP-1) analog that has been developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMEA) in 2009.

    CEK Liraglutide kit (CEK 0130-03) developed by AB Biolabs is a 96 wells competitive immunoassay. It can be applied for the analysis of Liraglutide in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.


AB Biolabs start new promotion program for product sale (04/01/2010)


   
Ballwin, Missouri. AB Biolabs started a new round of sales promotion from April 1st, 2010. Customers will be automatically entered to win a gift when meeting the minimum purchase requirement. Details about the promotion can be found in Products page, or through the link here.


AB Biolabs launches new produdts (02/15/2010)

    Ballwin, Missouri. AB Biolabs has added CEK 0130-02 Lixisenatide and SEK 0130-02 Lixisenatide assay kits to its product lines. Lixisenatide is a novel human glucagon-like peptide-1 receptor (GLP-1R) agonist for the treatment of type 2 diabetes mellitus (T2DM; non-insulin dependent diabetes). The structure of Lixisenatide is based on exendin-4(1-39), and is able to withstand physiological degradation by dipeptidyl peptidase IV.

    Developed by scientists of AB Biolabs, CEK Lixisenatide (CEK 0130-02) is a 96 wells competitive immunoassay, and SEK Lixisenatide (SEK 0130-02)  is a 96 wells sandwich immunoassay. Both kits can be applied for the analysis of Lixisenatide in serum, plasma, or tissue extracts in pharmacokinetics, peptide delivery study and other purposes.


AB Biolabs has launched a competitive immunoassay kit for Methionine-Enkephalin detection (11/18/2009) 


  
   Ballwin, Missouri. AB Biolabs has introduced a competitive immunoassay kit for detecting Methionine-Enkephalin, an endogenous opioid peptide neurotransmitter found naturally in the brains of many animals and humans. Scientists have found multiple immunologic actions of Methionine-Enkephalin to include activating NK-K-LAK cells in AIDS patients, modulating inflammatory processes and keratinocyte differentiation, stimulating dendritic cells as an adjuvant for vaccine immunization and immuno-supplement in cancer treatment et al.

     
 Methionine-Enkephalin kit (CEK 0230-00) offers standard 96-well assay format. It can be applied for analysis of Methionine-Enkephalin in serum, plasma, or tissue extracts in pharmacokinetics and peptide delivery studies, as well as for other purposes.